The Real-World Impact of CAR T-Cell Therapy in Large B-Cell Lymphoma - Episode 5

Real World Findings for Liso-Cel in LBCL From the Cell Therapy Consortium

,

Caron A. Jacobson, MD, discusses the significance of a real-world follow-up analysis of liso-cel in which safety and efficacy findings in patients with comorbidities and others who were not eligible for clinical trials were consistent with those studies.

EP. 1: The Expanding Utility of CAR T-Cell Therapy in LBCL
EP. 2: Sequencing With CAR T-Cell Therapy for LBCL
EP. 3: CAR T-Cell Therapy as a Second-Line Treatment for LBCL
EP. 4: Understanding Malignancy Risks With the Use of CAR T-cell Therapies
Now Viewing
EP. 5: Real World Findings for Liso-Cel in LBCL From the Cell Therapy Consortium
EP. 6: Expert Perspective on Real-World Follow-Up Analyses of Liso-Cel in LBCL
EP. 7: The Impact of Real-World Analyses in the Utilization of CAR T-Cell Therapy in LBCL
EP. 8: Bridging Therapy With CAR T-Cell Therapy in LBCL
EP. 9: The Future of CAR T-Cell Therapy in LBCL
EP. 10: Back to the Bench: Exploring the Potential of CAR T-Cell Therapy in Oncology